Carcinogenesis Advance Access originally published online on July 1, 2004
Carcinogenesis 2004 25(11):2165-2171; doi:10.1093/carcin/bgh217
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Carcinogenesis vol.25 no.11 © Oxford University Press 2004; all rights reserved.
ARTICLE |
Aberrant methylation of the FHIT gene in chronic smokers with early stage squamous cell carcinoma of the lung
1 Center for Genome Research, Samsung Biomedical Research Institute, Seoul, Korea 135-710, 2 Division of Pulmonary and Critical Care Medicine, Samsung Medical Center, Sungkyunkwan University, School of Medicine, Seoul, Korea 135-710, 3 Department of Thoracic Surgery, Samsung Medical Center, Sungkyunkwan University, School of Medicine, Seoul, Korea 135-710, 4 Department of Pathology, Samsung Medical Center, Sungkyunkwan University, School of Medicine, Seoul, Korea 135-710 and 5 Department of Molecular Cell Biology, Sungkyunkwan University, School of Medicine, Suwon, Korea 440-746
6 To whom correspondence should be addressed Email: dukhwan.kim{at}samsung.com
Fragile histidine triad (FHIT) gene plays an important role in the pathogenesis of lung cancer. However, the clinicopathological significance of CpG island hypermethylation of FHIT gene in non-small cell lung cancer (NSCLC) remains to be elucidated. We studied FHIT methylation in 254 NSCLCs in order to further understand the clinicopathological and prognostic significance of FHIT methylation in NSCLC. Methylation status of the FHIT gene was examined using Methylation-Specific PCR. All statistical analyses were two-sided, with a 5% type I error rate. Hypermethylation of the FHIT gene occurred more frequently in squamous cell carcinoma than adenocarcinoma. For 93 adenocarcinomas there was no statistically significant association between FHIT methylation and age, gender, smoking history, pathologic stage and p16 methylation. However, FHIT methylation in 125 squamous cell carcinomas was associated with exposure to tobacco smoke and p16 methylation, but not with age, gender and pathologic stage. Hypermethylation of FHIT in squamous cell carcinomas occurred more frequently in current smokers (45%) than in never-smokers (13%). FHIT methylation was significantly associated with p16 methylation in current- and ex-smokers (P = 0.02 and P = 0.01, respectively) with squamous cell carcinoma and in patients with pathologic stage I squamous cell carcinoma (P = 0.001). Patients with p16 methylation were 3.74 times [95% confidence interval (CI) = 1.62 – 7.95; P = 0.001] more likely to have FHIT methylation in squamous cell carcinoma. FHIT methylation in squamous cell carcinoma occurred at a 4.62 times (95% CI = 1.26 – 34.97; P = 0.02) higher prevalence in current smokers than in never-smokers. No prognostic effect of FHIT methylation was observed in stage I and stage II NSCLCs. In conclusion, hypermethylation of the FHIT gene did not have a prognostic significance in early stage NSCLCs. The FHIT methylation is associated with the p16 methylation and smoking in squamous cell carcinoma, suggesting that FHIT may cooperate with p16 for the development of squamous cell carcinoma of lung in individuals exposed to tobacco smoke.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  D. J. Stewart, J.-P. Issa, R. Kurzrock, M. I. Nunez, J. Jelinek, D. Hong, Y. Oki, Z. Guo, S. Gupta, and I. I. Wistuba Decitabine Effect on Tumor Global DNA Methylation and Other Parameters in a Phase I Trial in Refractory Solid Tumors and Lymphomas Clin. Cancer Res., June 1, 2009; 15(11): 3881 - 3888. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Verri, L. Roz, D. Conte, T. Liloglou, A. Livio, A. Vesin, A. Fabbri, F. Andriani, C. Brambilla, L. Tavecchio, et al. Fragile Histidine Triad Gene Inactivation in Lung Cancer: The European Early Lung Cancer Project Am. J. Respir. Crit. Care Med., March 1, 2009; 179(5): 396 - 401. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T M Murphy, A S Perry, and M Lawler The emergence of DNA methylation as a key modulator of aberrant cell death in prostate cancer Endocr. Relat. Cancer, March 1, 2008; 15(1): 11 - 25. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Gu, D. Berman, C. Lu, I. I. Wistuba, J. A. Roth, M. Frazier, M. R. Spitz, and X. Wu Aberrant Promoter Methylation Profile and Association with Survival in Patients with Non-Small Cell Lung Cancer Clin. Cancer Res., December 15, 2006; 12(24): 7329 - 7338. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. D'Agostini, A. Izzotti, R. Balansky, N. Zanesi, C. M. Croce, and S. De Flora Early loss of fhit in the respiratory tract of rodents exposed to environmental cigarette smoke. Cancer Res., April 1, 2006; 66(7): 3936 - 3941. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Wali, R. Srinivasan, M. S. Shabnam, S. Majumdar, K. Joshi, and D. Behera Loss of Fragile Histidine Triad Gene Expression in Advanced Lung Cancer Is Consequent to Allelic Loss at 3p14 Locus and Promoter Methylation Mol. Cancer Res., February 1, 2006; 4(2): 93 - 99. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. T. Kim, S. J. Park, S. H. Lee, H. J. Kang, S. Hahn, C. H. Kang, S. W. Sung, and J. H. Kim Prognostic implication of aberrant promoter hypermethylation of CpG islands in adenocarcinoma of the lung J. Thorac. Cardiovasc. Surg., November 1, 2005; 130(5): 1378 - 1378. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. H. Holschneider, R. L. Baldwin, K. Tumber, C. Aoyama, and B. Y. Karlan The Fragile Histidine Triad Gene: A Molecular Link Between Cigarette Smoking and Cervical Cancer Clin. Cancer Res., August 15, 2005; 11(16): 5756 - 5763. [Abstract] [Full Text] [PDF]
|
|